Iradimed

Yahoo Finance • 30 days ago

IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference

ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, today announced that... Full story

Yahoo Finance • 2 months ago

Iradimed (IRMD) Q2 Revenue Jumps 14%

Key Points Revenue (GAAP) grew 14% year over year to $20.41 million in the second quarter of 2025, exceeding both company guidance and analyst expectations for non-GAAP EPS. Non-GAAP earnings per share reached $0.49, beating non-GAAP EPS... Full story

Yahoo Finance • 4 months ago

Iradimed rises after FDA nod for infusion pump system

[FDA headquarters in Washington DC.] JHVEPhoto * Shares of Iradimed (NASDAQ:IRMD [https://seekingalpha.com/symbol/IRMD]) jumped on Thursday after the MedTech announced the FDA’s 510((k)) clearance for its next MRidium 3870 IV infusion p... Full story

Yahoo Finance • 4 months ago

IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System

WINTER SPRINGS, Fla., May 29, 2025 (GLOBE NEWSWIRE) -- Iradimed Corporation (NASDAQ: IRMD), a global leader in innovative medical devices for MRI environments, today announced that the U.S. Food and Drug Administration (FDA) has granted... Full story

Yahoo Finance • 4 months ago

Analysts Anticipate 25% Gains Ahead For The Holdings of FHLC

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • 7 months ago

IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference

WINTER SPRINGS, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that it will participate in the 37th Annual Roth Conference. Iradimed’s CFO, Jack Glenn, and CCO, Jeff Chiprin,... Full story

Yahoo Finance • 8 months ago

IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

WINTER SPRINGS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 fourth quarter financial results before the market opens on Thursday, February 13, 2025. I... Full story

Yahoo Finance • 2 years ago

IRADIMED CORPORATION Named a 2024 Most Successful Small-Cap Company in America by Forbes

WINTER SPRING, Fla., Nov. 30, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) was recently named on Forbes’ latest list of America’s Most Successful Small-Cap Companies for 2024. Iradimed is a leader in the d... Full story

Yahoo Finance • 2 years ago

IRADIMED CORPORATION Announces Third Quarter 2023 Financial Results

Reports record revenue of $16.5 million for the third quarter of 2023. GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43. Third quarter operating income of $5.9 million, an increase of 43% compared to the same period in 2022. WI... Full story

Yahoo Finance • 2 years ago

IRADIMED CORPORATION to Hold 2023 Third Quarter Financial Results Conference Call on November 3rd

WINTER SPRINGS, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 third quarter financial results before the market opens on Friday, November 3rd. IRADIMED... Full story

Yahoo Finance • 2 years ago

IRADIMED CORPORATION to Participate at Upcoming Investor Conferences

WINTER SPRINGS, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences. Iradimed management is scheduled t... Full story

Yahoo Finance • 2 years ago

IRADIMED CORPORATION Announces First Quarter 2023 Financial Results

Reports record revenue of $15.5 million for the first-quarter quarter of 2023 GAAP diluted EPS of $0.27 and non-GAAP diluted EPS of $0.30 Operating income was $4.0 million and increased by 30% Announces second quarter 2023 financial gui... Full story

Yahoo Finance • 3 years ago

IRADIMED CORPORATION To Present at the 35th Annual Roth Conference

WINTER SPRINGS, Fla., March 06, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Rot... Full story

Yahoo Finance • 3 years ago

IRADIMED CORPORATION Issues Urgent Medical Device Correction

WINTER SPRINGS, Fla., Feb. 24, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a potential issue with some 1057 Syringe Adapte... Full story

Yahoo Finance • 3 years ago

IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend

Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32. Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and non-GAAP diluted EPS of $1.10.The Board of Di... Full story

Yahoo Finance • 3 years ago

IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022

Reports preliminary fourth quarter 2022 revenue of $14.9 million Announces full-year and first-quarter 2023 financial guidance WINTER SPRINGS, Fla., Jan. 18, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) t... Full story

Yahoo Finance • 3 years ago

IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results

Revenue was $13.4 million and increased by 23% Operating income was $4.1 million and increased 32%GAAP diluted EPS was $0.27 and increased by 35%Announces fourth quarter 2022 financial guidance WINTER SPRINGS, Fla., Nov. 03, 2022 (GLOBE... Full story

Yahoo Finance • 3 years ago

IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd

WINTER SPRINGS, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market opens on Thursday, November 3rd. IRADIME... Full story

Yahoo Finance • 3 years ago

IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA

WINTER SPRINGS, Fla., Oct. 10, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that the Company voluntarily withdrew its 510(K) application on October 5, 2022, for its next-generation MR IV pu... Full story

Yahoo Finance • 3 years ago

IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results

Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial guidance WINTER SPRINGS, Fla., July 29, 2022 (GLOBE NEWSWIRE) -- IRADIMED CORPORATIO... Full story